Search and analyze individual stocks with comprehensive metrics
Sanrhea Tech.
Fundamental Score
Sanrhea Tech. Share Price & Market Analysis
Profitability Metrics
Return on Equity
Return on Capital Employed
Operating Profit Margin (5Y)
Dividend Yield
Valuation Metrics
Price to Earnings
Market Capitalization
Industry P/E
Growth Metrics
YoY Quarterly Profit Growth
YoY Quarterly Sales Growth
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Financial Health
Debt to Equity
Interest Coverage
Free Cash Flow (5Y)
Ownership Structure
Promoter Holding
FII Holding
DII Holding
Pledged Percentage
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Market Data Analysis & Educational Insights
Educational evaluation of SANTETX across key market metrics for learning purposes.
Positive Indicators
9 factors identified
Strong Return on Equity (19.86%)
Observation: Efficient use of shareholders' capital generating superior returns.
Analysis: ROE >15% indicates strong profitability and effective management. This metric suggests the company can generate substantial returns on invested capital.
Excellent ROCE Performance (22.79%)
Observation: Superior returns on capital employed across business operations.
Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance. This indicates quality business fundamentals.
Attractive Valuation (P/E: 16.86 vs Industry: 22.73)
Observation: Trading at discount to industry peers.
Analysis: P/E below industry average may present value opportunity if fundamentals support the business case.
Consistent Growth Track Record (16.91% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model and market opportunity execution over time.
Excellent EPS Growth (40.72% CAGR)
Observation: Outstanding 5-year earnings per share compound growth.
Analysis: EPS CAGR >15% indicates strong wealth creation potential and effective capital allocation over extended periods.
Strong Profit Growth Track Record (46.03% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model and effective operational leverage over time.
Strong Interest Coverage (5.79x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk and strong debt servicing capability.
Balanced Promoter Holding (74.98%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment while ensuring adequate liquidity.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral, reducing forced-selling risk.
Analysis: Absence of share pledging eliminates potential forced-selling pressure during market stress.
Risk Factors
1 factors identified
Small Market Cap
Observation: Higher investment risk due to limited size.
Analysis: Small-cap stocks typically carry higher volatility and liquidity risks.
📊 Educational Market Overview
Disclaimer: The ratings and scores are generated algorithmically from publicly available market data and are provided for educational and informational purposes only. They do not constitute investment advice, recommendation, or solicitation to buy/sell any securities.
Loading Peer Comparison
Finding companies in the Other Textile Products sector...
Financial Statements
Comprehensive financial data for Sanrhea Tech.
About SANTETX
Company Details
Market Information
Performance
SANTETX Stock Details & Analysis
Key Financial Metrics
Growth & Valuation
Frequently Asked Questions
What is the current price of SANTETX?
SANTETX is currently trading at ₹138.90 with a gain of 0.00% today. The current market price (CMP) represents the last traded price of SANTETX shares on the stock exchange. This price fluctuates throughout trading hours based on supply and demand. You can track real-time price movements, percentage changes, and trading volume in the header section.
What is the P/E ratio of SANTETX and what does it mean?
SANTETX has a P/E ratio of 16.86x compared to the industry average of 22.73x. The Price-to-Earnings (P/E) ratio is calculated by dividing the current share price by earnings per share (EPS). This means investors are paying ₹17 for every ₹1 of annual earnings. This is lower than the industry average, which might indicate undervaluation or slower growth expectations.
How is SANTETX performing according to Bull Run's analysis?
SANTETX has a Bull Run fundamental score of 50.7/100, which indicates moderate strength with some areas for improvement. This comprehensive rating is based on 15+ financial parameters including profitability (ROE: 19.86%), growth metrics, valuation ratios, and financial health indicators. The score updates quarterly with new financial data and helps you quickly assess overall investment quality.
What sector and industry does SANTETX belong to?
SANTETX operates in the Textiles & Apparels industry. This sector classification helps understand the broader economic trends, regulatory framework, and competitive landscape affecting Sanrhea Tech.. Companies in this industry typically face similar market dynamics, cyclical patterns, and macroeconomic factors. Understanding the industry context is crucial for peer comparison and assessing how sector-specific trends might impact the stock's performance.
What is Return on Equity (ROE) and why is it important for SANTETX?
SANTETX has an ROE of 19.86%, which indicates excellent management efficiency and profitable operations. Return on Equity measures how efficiently Sanrhea Tech. generates profits from shareholders' equity. An ROE of 20% means the company generates ₹20 profit for every ₹100 of shareholders' equity. This metric is crucial for assessing management's ability to create value for shareholders.
How is SANTETX's debt-to-equity ratio and what does it indicate?
SANTETX has a debt-to-equity ratio of 0.55, which indicates moderate leverage that should be monitored. This means the company has ₹55 of debt for every ₹100 of equity. Higher leverage can amplify returns during good times but increases bankruptcy risk during downturns.
What is SANTETX's dividend yield and is it a good dividend stock?
SANTETX offers a dividend yield of 1.06%, which means you receive ₹1.06 annual dividend for every ₹100 invested. The focus appears to be more on growth rather than dividend income. Dividend yield is calculated as annual dividend per share ÷ current share price × 100. Evaluate dividend consistency over 5+ years and free cash flow coverage for sustainability.
How has SANTETX grown over the past 5 years?
SANTETX has achieved 5-year growth rates of: Sales Growth 16.91%, Profit Growth 46.03%, and EPS Growth 40.72%. This consistent double-digit growth indicates a strong business model and competitive positioning. Sales growth indicates market expansion, profit growth shows operational efficiency, and EPS growth directly impacts share price appreciation potential.
What is the promoter holding in SANTETX and why does it matter?
Promoters hold 74.98% of SANTETX shares, with 0.00% of promoter shares pledged. This high promoter holding indicates strong management confidence and alignment with shareholders. Low pledging indicates financial stability of promoters. Recent change in promoter holding: 3.46%.
How does SANTETX compare with its industry peers?
SANTETX trades at P/E 16.86x vs industry average 22.73x, with ROE of 19.86% and ROCE of 22.79%. The stock appears undervalued relative to peers based on P/E ratio. Peer comparison helps identify whether SANTETX is outperforming its competitive set in profitability, growth, and valuation metrics.
What is SANTETX's market capitalization and what category does it fall into?
SANTETX has a market capitalization of ₹80 crores, making it a Mid-cap stock. Mid-cap stocks balance growth potential with moderate risk. Market cap is calculated as current share price × total outstanding shares, representing the company's total market value.
What are the key financial ratios to consider for SANTETX?
Key ratios for SANTETX: ROE 19.86% (Excellent), ROCE 22.79%, P/E 16.86x, Debt-to-Equity 0.55, Interest Coverage 5.79x. These ratios help assess profitability (ROE, ROCE), valuation (P/E), financial health (D/E, Interest Coverage), and overall investment quality. Compare these with industry medians and historical trends for meaningful analysis.
How volatile is SANTETX stock and what is its beta?
SANTETX has a beta of N/A, which means it is less volatile than the market and offers defensive characteristics. Beta measures price volatility relative to the Nifty 50. Lower beta stocks provide stability during uncertain market conditions. Consider beta alongside your risk tolerance and portfolio diversification strategy.
What is the 52-week high and low for SANTETX?
SANTETX has a 52-week high of ₹N/A and low of ₹N/A. Currently trading at ₹138.90, the stock is within its annual trading range. Trading near highs indicates strong momentum but limited upside potential.
What are the key risks associated with investing in SANTETX?
Key risks for SANTETX include: Market volatility (Beta: N/A), financial leverage (Debt-to-Equity: 0.55), and operational challenges. The stock has a Fundamental Score of 50.7/100, indicating moderate risk requiring careful monitoring. Sector-specific risks in Textiles & Apparels include regulatory changes, economic cycles, and competitive pressures. Consider your risk tolerance, investment horizon, and portfolio diversification before investing. Past performance doesn't guarantee future results.
What is SANTETX's operating profit margin and how has it trended?
SANTETX has a 5-year average Operating Profit Margin (OPM) of 11.38%, which is good and shows decent operational efficiency. Operating Profit Margin shows operational efficiency by measuring operating profit as a percentage of revenue. Monitor margin trends to assess management's ability to control costs and improve efficiency. Compare with industry peers to understand relative performance.
How is SANTETX's quarterly performance in terms of sales and profit growth?
SANTETX's recent quarterly performance shows YoY Sales Growth of 5.28% and YoY Profit Growth of 3.12%. Growth rates indicate the current business trajectory and market demand. Sales growth shows market demand while profit growth reveals operational efficiency and margin management.
What is the FII and DII holding pattern in SANTETX?
SANTETX has FII holding of 0.00% and DII holding of 0.00%, totaling 0.00% institutional ownership. This institutional participation level shows the confidence of professional money managers. Monitor quarterly changes in institutional holdings for investment flow trends and sentiment.